← Back to Search

Health Coaching for Breast Cancer Survivors

N/A
Recruiting
Led By Bridget A Oppong, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Black women \> 18 years of age with stage I-III primary breast cancer who have completed definitive breast cancer treatmen
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a navigation program to help Black breast cancer survivors access physical, emotional, and nutritional support and improve their quality of life.

Who is the study for?
This trial is for Black women over the age of 18 who have been treated for stage I-III primary breast cancer and are now finished with their main treatment. It's designed to support these survivors as they transition out of active treatment.
What is being tested?
The study tests a coaching-based navigation program that helps participants access resources for physical rehab, emotional support, and guidance on nutrition and exercise to potentially improve their quality of life after breast cancer treatment.
What are the potential side effects?
Since this trial involves patient navigation and lifestyle coaching rather than medical treatments, there are no direct side effects like those associated with drugs or surgery. However, participants may experience varying levels of psychological impact.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Breast Cancer Self Efficacy Scale score
Consent rate
Dropout rate
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health services research (patient navigator)Experimental Treatment3 Interventions
Patients are assigned a Black patient navigator for racial concordance and receive coaching from patient navigator over 30 minutes every other week for 3 months and then monthly for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
342 Previous Clinical Trials
293,167 Total Patients Enrolled
23 Trials studying Breast Cancer
2,902 Patients Enrolled for Breast Cancer
Bridget A Oppong, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Patient Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05674578 — N/A
Breast Cancer Research Study Groups: Health services research (patient navigator)
Breast Cancer Clinical Trial 2023: Patient Navigation Highlights & Side Effects. Trial Name: NCT05674578 — N/A
Patient Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05674578 — N/A
~0 spots leftby Dec 2024